At the moment, there is hardly any structured safety and efficacy data collection on
Tiotropium in Russia. Therefore, the objective of this observational study is to collect and
evaluate data on bronchodilator efficacy and safety of Spiriva® (18 µg tiotropium inhalation
capsules) delivered by HandiHaler®, in a national sample of Russian patients with varying
severities of chronic obstructive pulmonary disease (COPD) in a real life setting over the 8
weeks.